Diary - News
All news CarThera’s SonoCloud technology enhances the efficacy of immunotherapies for the treatment of brain tumors
Article published in AACR’s Clinical Cancer Research journal describes results of preclinical work
Paris, France, June 9, 2021 – CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces preclinical results in the testing of the combination of SonoCloud® technology with immunotherapies. This laboratory work was done in collaboration with Dr Amy Heimberger – a renowned expert in immunotherapies for glioblastoma (GBM) at the MD Anderson Cancer Center. The results were recently published online in the prestigious Clinical Cancer Research journal: ‘Opening of blood-brain barrier using low-intensity pulsed ultrasound (LIPU) enhances responses to immunotherapy in preclinical glioma models’.